BR9814546A - "liberação de dna de plasmìdeo codificando polipeptìdeos no citossol de macrófagos por bactérias suicidas atenuadas" - Google Patents
"liberação de dna de plasmìdeo codificando polipeptìdeos no citossol de macrófagos por bactérias suicidas atenuadas"Info
- Publication number
- BR9814546A BR9814546A BR9814546-0A BR9814546A BR9814546A BR 9814546 A BR9814546 A BR 9814546A BR 9814546 A BR9814546 A BR 9814546A BR 9814546 A BR9814546 A BR 9814546A
- Authority
- BR
- Brazil
- Prior art keywords
- bacteria
- release
- attenuated
- plasmid dna
- suicidal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
- C12N15/877—Techniques for producing new mammalian cloned embryos
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Patente de Invenção: <B>"LIBERAçãO DE DNA DE PLASMìDEO CODIFICANDO POLIPEPTìDEOS NO CITOSSOL DE MACRóFAGOS POR BACTéRIAS SUICIDAS ATENUADAS"<D>. A invenção refere-se à introdução de seq³ências de DNA ou RNA em uma célula de mamífero para obter expressão controlada de um polipeptídeo. é portanto útil em terapia genética, vacinação, e qualquer situação terapêutica na qual um polipeptídeo deve ser administrado a um hospedeiro ou células dos hospedeiros referidos, bem como para a produção de polipeptídeos de células de mamíferos, por exemplo, em cultura ou em animais transgênicos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/999,391 US6143551A (en) | 1997-12-29 | 1997-12-29 | Delivery of polypeptide-encoding plasmid DNA into the cytosol of macrophages by attenuated listeria suicide bacteria |
PCT/EP1998/008345 WO1999034007A1 (en) | 1997-12-29 | 1998-12-18 | Delivery of polypeptide-encoding plasmid dna into the cytosol of macrophages by attenuated suicide bacteria |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9814546A true BR9814546A (pt) | 2000-10-10 |
Family
ID=25546276
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9814546-0A BR9814546A (pt) | 1997-12-29 | 1998-12-18 | "liberação de dna de plasmìdeo codificando polipeptìdeos no citossol de macrófagos por bactérias suicidas atenuadas" |
Country Status (11)
Country | Link |
---|---|
US (2) | US6143551A (pt) |
EP (1) | EP1042495A1 (pt) |
JP (1) | JP2002500017A (pt) |
KR (1) | KR100606322B1 (pt) |
AU (1) | AU753888B2 (pt) |
BR (1) | BR9814546A (pt) |
CA (1) | CA2317111A1 (pt) |
HU (1) | HUP0100994A3 (pt) |
IL (2) | IL136455A0 (pt) |
PL (1) | PL194123B1 (pt) |
WO (1) | WO1999034007A1 (pt) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040242520A1 (en) * | 1997-09-06 | 2004-12-02 | Mayo Foundation For Medical Education And Research, A Minnesota Corporation | Expression of immonogenic substances |
US6080849A (en) * | 1997-09-10 | 2000-06-27 | Vion Pharmaceuticals, Inc. | Genetically modified tumor-targeted bacteria with reduced virulence |
US6962696B1 (en) * | 1999-10-04 | 2005-11-08 | Vion Pharmaceuticals Inc. | Compositions and methods for tumor-targeted delivery of effector molecules |
DE19949594A1 (de) * | 1999-10-14 | 2001-04-26 | Deutsches Krebsforsch | Rekombinante attenuierte Listerien zur Immuntherapie |
WO2003103578A2 (en) * | 2002-06-05 | 2003-12-18 | Iowa State University Research Foundation, Inc. | Bacteriophage and enzymes lytic to salmonellae |
US20050214264A1 (en) * | 2002-12-13 | 2005-09-29 | Cosenza Lawrence W | Sacromastigophoric therapeutic agent delivery system |
EP1592442A2 (en) * | 2003-02-06 | 2005-11-09 | Cerus Corporation | Modified free-living microbes, vaccine compositions and methods of use thereof |
US7695725B2 (en) * | 2003-02-06 | 2010-04-13 | Aduro Biotech | Modified free-living microbes, vaccine compositions and methods of use thereof |
CA2515369C (en) * | 2003-02-06 | 2015-03-31 | Cerus Corporation | Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the listeria, and methods of use thereof |
DE10326189A1 (de) * | 2003-06-06 | 2005-01-05 | MedInnova Gesellschaft für medizinische Innovationen aus akademischer Forschung mbH | Bakterielle Träger für Nukleotidsequenzen kodierend für Wirkstoffe |
US7390646B2 (en) * | 2003-09-17 | 2008-06-24 | The Regents Of The University Of California | Bacterial vectors and methods of use thereof |
US20070298012A1 (en) * | 2003-12-16 | 2007-12-27 | Ivan King | Compositions and Methods for Tumor-Targeted Delivery of Effector Molecules |
US7842289B2 (en) | 2003-12-24 | 2010-11-30 | Aduro Biotech | Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof |
WO2006014746A1 (en) | 2004-07-23 | 2006-02-09 | Henkin-Laby, Llc | Swimming pool cleaner debris container |
WO2006137836A2 (en) * | 2004-08-17 | 2006-12-28 | Research Development Foundation | Bacterial vector systems |
DE602005023345D1 (de) * | 2004-12-17 | 2010-10-14 | Beth Israel Hospital | Zusammensetzungen für bakteriell vermitteltes gen-silencing sowie verfahren zur verwendung davon |
BRPI0611535B1 (pt) | 2005-05-05 | 2021-11-30 | Sensient Flavors Inc | Método para processar células de levedura para produzir beta-glucanos e mananas |
US20080124355A1 (en) | 2006-09-22 | 2008-05-29 | David Gordon Bermudes | Live bacterial vaccines for viral infection prophylaxis or treatment |
US8241623B1 (en) | 2009-02-09 | 2012-08-14 | David Bermudes | Protease sensitivity expression system |
US8771669B1 (en) | 2010-02-09 | 2014-07-08 | David Gordon Bermudes | Immunization and/or treatment of parasites and infectious agents by live bacteria |
US9597379B1 (en) | 2010-02-09 | 2017-03-21 | David Gordon Bermudes | Protease inhibitor combination with therapeutic proteins including antibodies |
US8524220B1 (en) | 2010-02-09 | 2013-09-03 | David Gordon Bermudes | Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria |
US20150224181A1 (en) | 2012-09-14 | 2015-08-13 | The United States Of America As Represented By The Secretary Department Of Health And Human Se | Brachyury protein, non-poxvirus non-yeast vectors encoding brachyury protein, and their use |
US9593339B1 (en) | 2013-02-14 | 2017-03-14 | David Gordon Bermudes | Bacteria carrying bacteriophage and protease inhibitors for the treatment of disorders and methods of treatment |
TWI658140B (zh) * | 2015-11-12 | 2019-05-01 | 昕穎生醫技術股份有限公司 | 表現異源基因的系統及其用途 |
US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2255561B (en) * | 1991-04-20 | 1995-06-21 | Agricultural & Food Res | Lysins from bacteriophages |
WO1996007756A1 (de) * | 1994-09-09 | 1996-03-14 | Jsd Technologies, Ltd. | Aufschluss von bakterienzellen durch phagenlysine |
US5877159A (en) * | 1995-05-03 | 1999-03-02 | University Of Maryland At Baltimore | Method for introducing and expressing genes in animal cells and live invasive bacterial vectors for use in the same |
CA2231332C (en) * | 1995-09-06 | 2007-04-17 | Arthur A. Branstrom | Bacterial delivery system |
-
1997
- 1997-12-29 US US08/999,391 patent/US6143551A/en not_active Expired - Fee Related
-
1998
- 1998-12-18 HU HU0100994A patent/HUP0100994A3/hu unknown
- 1998-12-18 JP JP2000526662A patent/JP2002500017A/ja active Pending
- 1998-12-18 IL IL13645598A patent/IL136455A0/xx not_active IP Right Cessation
- 1998-12-18 CA CA002317111A patent/CA2317111A1/en not_active Abandoned
- 1998-12-18 BR BR9814546-0A patent/BR9814546A/pt not_active Application Discontinuation
- 1998-12-18 PL PL98341530A patent/PL194123B1/pl unknown
- 1998-12-18 KR KR1020007007207A patent/KR100606322B1/ko not_active IP Right Cessation
- 1998-12-18 EP EP98965287A patent/EP1042495A1/en not_active Withdrawn
- 1998-12-18 WO PCT/EP1998/008345 patent/WO1999034007A1/en active IP Right Grant
- 1998-12-18 AU AU20547/99A patent/AU753888B2/en not_active Ceased
-
2000
- 2000-03-22 US US09/532,964 patent/US20020045587A1/en not_active Abandoned
- 2000-05-30 IL IL136455A patent/IL136455A/en unknown
Also Published As
Publication number | Publication date |
---|---|
PL341530A1 (en) | 2001-04-23 |
KR20010033684A (ko) | 2001-04-25 |
IL136455A (en) | 2007-06-03 |
HUP0100994A2 (hu) | 2001-07-30 |
PL194123B1 (pl) | 2007-04-30 |
US6143551A (en) | 2000-11-07 |
WO1999034007A1 (en) | 1999-07-08 |
IL136455A0 (en) | 2001-06-14 |
KR100606322B1 (ko) | 2006-08-02 |
JP2002500017A (ja) | 2002-01-08 |
US20020045587A1 (en) | 2002-04-18 |
AU753888B2 (en) | 2002-10-31 |
AU2054799A (en) | 1999-07-19 |
HUP0100994A3 (en) | 2003-10-28 |
EP1042495A1 (en) | 2000-10-11 |
CA2317111A1 (en) | 1999-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9814546A (pt) | "liberação de dna de plasmìdeo codificando polipeptìdeos no citossol de macrófagos por bactérias suicidas atenuadas" | |
US10927383B2 (en) | Cas9 mRNAs | |
Geurts et al. | Gene transfer into genomes of human cells by the sleeping beauty transposon system | |
JP2022095633A (ja) | ヌクレアーゼ非依存的な標的化遺伝子編集プラットフォームおよびその用途 | |
AU2003298574B2 (en) | Use of chimeric nucleases to stimulate gene targeting | |
Martinet et al. | Nucleofection as an efficient nonviral transfection method for human monocytic cells | |
JP2023089132A (ja) | 細胞の遺伝子修飾のための非組込みdnaベクター | |
AU2019362874A1 (en) | Programmable DNA base editing by Nme2Cas9-deaminase fusion proteins | |
KR100490188B1 (ko) | 진핵 세포에서의 서열 특이적 dna 재조합 | |
BR9914643A (pt) | Vetores adeno-associados para expressão dofator viii por células alvo | |
CA2361191A1 (en) | Gene repair involving the induction of double-stranded dna cleavage at a chromosomal target site | |
EE200300332A (et) | Rekombinantne MVA viirus ja selle kasutamine, isoleeritud eukarüootne rakk, meetod rekombinantse hTyr-proteiini valmistamiseks ning vaktsiin | |
BR9610511B1 (pt) | construções de dna, úteis em terapia genética, compreendendo ao menos uma sequência nucléica de interesse e composição farmacêutica. | |
Razin et al. | Nuclear matrix attachment regions and topoisomerase II binding and reaction sites in the vicinity of a chicken DNA replication origin | |
CA2360878A1 (en) | Gene repair involving excision of targeting dna | |
IT1298487B1 (it) | Composizioni farmaceutiche comprendenti pentraxina lunga ptx3 per la terapia di patologie di tipo infettivo, infiammatorio o tumorale, | |
WO2003076561A3 (en) | Recombinase fusion protein with enhanced cellular uptake | |
WO1999047678A3 (en) | Interferon alpha plasmids and delivery systems, and methods of making and using the same | |
KR101442254B1 (ko) | 최적의 진핵 세포 발현 벡터의 개발 | |
HUP0101355A2 (hu) | Fehérjetermelésre és célba juttatására szolgáló genomi szekvenciák | |
ATE420199T1 (de) | Wirtszellen, die rekombinantes humanes erythropoietin exprimieren | |
JPWO2019194320A1 (ja) | エンジニアリングされたBlCas9ヌクレアーゼ | |
NZ522360A (en) | Regulatory nucleic acid for the ABC1 gene, molecules modifying its activity and therapeutic uses | |
Eck | The prospects for gene therapy | |
MEI et al. | Sustained expression of Epstein–Barr virus episomal vector mediated factor VIII in vivo following muscle electroporation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |